Rigakafin cutar kyanda
Me yasa hana? |
Ko da yake cutar kyanda tana da sauki a cikin 90 % na lokuta, yana iya haifar da rikitarwa masu yuwuwar mutuwa, gami da encephalitis, da kuma asibiti don ciwon huhu. Da yake cuta ce mai saurin yaduwa, yin allurar rigakafi na yawancin jama'a (95%) ya zama dole don dakatar da yaduwar kwayar cutar. |
Za mu iya hanawa? |
Hanya mafi kyau don rigakafin cutar kyanda ita ce a yi musu allurar rigakafi da kuma yi wa yaranku allurar rigakafi. Ana samun maganin alurar riga kafi a cikin nau'i mai hade kuma yana ba da kariya mai inganci daga cutar kyanda, mumps da rubella ("MMR"). Ya kamata a ba yara allurai biyu, ɗaya yana da watanni 12, ɗayan kuma tsakanin watanni 13 zuwa 24. Ana kuma ba da shawarar allurar rigakafin “kamawa” a Faransa don yaran da ba a yi musu allurar ba fiye da shekaru 2, matasa da matasa ba a yi musu allurar a cikin shekaru 30 ba, da kuma kwararrun masana kiwon lafiya. A ka'idar, tabbataccen kawar da cutar kyanda a duniya yana yiwuwa, saboda maganin yana da tasiri sosai: yana ba da kariya 90% bayan kashi ɗaya kuma fiye da 95% bayan allurai biyu.3. |
Matakan kariya na asali |
Lokacin da aka gano cutar kyanda, ita ce batun a Faransa na sanarwar wajibi da likita ya yi ga Sabis na Kula da Lafiya na Hukumar Lafiya ta Yanki. Dole ne a ware majiyyaci a duk tsawon lokacin kamuwa da cuta, wato har zuwa kwanaki 5 bayan farawar kurji. A Quebec, ana ba da rahoton shari'o'i ga Ofishin Kulawa da Kulawa na Ma'aikatar Lafiya da Sabis na Jama'a. Mutanen da suka yi hulɗa da majiyyaci za a iya yi musu rigakafin idan ba su rigaya ba. Dangane da lamarin, ana kuma iya ba su maganin rigakafi ta cikin jijiya (bisa ga immunoglobulins). Wannan yana taimakawa wajen kare masu rauni, musamman mata masu juna biyu, yara da ba su kai watanni 12 ba, ko kuma mutanen da ke da ƙarancin rigakafi.4. |
ra'ayi : Faduwa a cikin adadin alurar riga kafi a kan kyanda A cikin 'yan shekarun nan an bayyana wani bangare ta hanyar imani cewa maganin MMR zai iya sa wasu yara su yi rashin lafiya, biyo bayan wallafa wani binciken da Dr. Wakefield ya yi a 1998. Tun daga wannan lokacin, yawancin bincike sun yi musun kasancewar wata ƙungiya tsakanin rigakafin MMR da kuma maganin rigakafi. cututtuka na autistic5. A cikin wani ra'ayi na Janairu 28, 2010, Majalisar Kula da Lafiya ta Biritaniya, daidai da Majalisar Kwalejin Kwalejin Likitoci, ta yi tir da rashin ƙarfi da amincin kimiyyar binciken Dr. Wakefiled, da kuma keta ka'idojin likitanci.6. Mujallar The Lancet, wadda a cikinta aka buga wannan aikin, har ma ta goge labarin a asalin takaddamar. Gabaɗayan al'ummar kimiyya sun yarda cewa babu wani ƙarin haɗarin zama autistic bayan wannan rigakafin.